terameprocol has been researched along with Experimental Neoplasms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chang, CC; Chung, Y; Henry, RA; Huang, RC; Liang, YC; Lin, E; Mold, DE; Park, R | 1 |
Heller, JD; Huang, RC; Kast, WM; Kuo, J; Wu, TC | 1 |
2 other study(ies) available for terameprocol and Experimental Neoplasms
Article | Year |
---|---|
Systemic treatment with tetra-O-methyl nordihydroguaiaretic acid suppresses the growth of human xenograft tumors.
Topics: Administration, Oral; Animals; Area Under Curve; CDC2 Protein Kinase; Cell Line, Tumor; Cell Proliferation; Cell Survival; Gene Expression Regulation, Neoplastic; HT29 Cells; Humans; Inhibitor of Apoptosis Proteins; Injections, Intravenous; K562 Cells; Masoprocol; Mice; Mice, Inbred C57BL; Mice, Inbred ICR; Microtubule-Associated Proteins; Neoplasm Proteins; Neoplasms, Experimental; RNA, Messenger; Survivin; Tissue Distribution; Xenograft Model Antitumor Assays | 2005 |
Tetra-O-methyl nordihydroguaiaretic acid induces G2 arrest in mammalian cells and exhibits tumoricidal activity in vivo.
Topics: Animals; CDC2 Protein Kinase; Cell Division; Cell Line, Transformed; G2 Phase; Masoprocol; Mice; Mice, Inbred C57BL; Neoplasm Transplantation; Neoplasms, Experimental; RNA, Messenger | 2001 |